The 2022 program will feature insights from top investors and biopharma executives by:

• Examining how the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics.
• Providing updates in hot therapeutic areas such as oncology, CNS, cell and gene therapy, rare disease.
• Exploring how COVID-19 accelerated the adoption of all things digital through the Digital Medicine & Medtech Showcase program.
• Showcasing the promise of early-stage innovation through the Seed Showcase program.

Our CEO & Co-founder, Tim Guilliams, will be speaking about how we are developing a new approach to drug discovery in order to address the huge unmet need of treatments for rare disease patients.

We’re looking forward to what’s set to be an insightful session. Will we see you there? If you aren’t attending but would like to learn more about our work, please contact us for more information.